RICHARD M ZWEIG

Allopathic & Osteopathic Physicians|Internal Medicine BRISTOL, CT NPI 1477548451

General Payments — all program years on this page

$3,959.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 243
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $301.21 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $254.6912
Education $46.522

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $191.068
Gilead Sciences, Inc. $56.933
Merck Sharp & Dohme Corporation $25.641
Amgen Inc. $14.121
Lilly USA, LLC $13.461

By program year

Program yearAmountRecords
2018 $1,498.19100
2019 $1,520.0196
2020 $303.3118
2021 $29.192
2022 $97.503
2023 $210.1210
2024 $301.2114

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104301660 AstraZeneca Pharmaceuticals LP $34.68 03/28/2024 Education Undisputed 01/23/2026 View at CMS
1104303780 AstraZeneca Pharmaceuticals LP $16.98 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104329164 AstraZeneca Pharmaceuticals LP $16.10 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104528784 AstraZeneca Pharmaceuticals LP $38.60 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104623640 AstraZeneca Pharmaceuticals LP $11.84 06/12/2024 Education Undisputed 01/23/2026 View at CMS
1104703813 AstraZeneca Pharmaceuticals LP $15.78 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104715697 AstraZeneca Pharmaceuticals LP $16.46 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104723237 AstraZeneca Pharmaceuticals LP $40.62 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726705 Amgen Inc. $14.12 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133750764 Gilead Sciences, Inc. $13.38 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133750766 Gilead Sciences, Inc. $27.04 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133750768 Gilead Sciences, Inc. $16.51 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135334831 Lilly USA, LLC $13.46 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141770860 Merck Sharp & Dohme LLC $25.64 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.